Latvia's AstraZeneca vaccine was transported in 'too cold' conditions

On Sunday, February 7, the first batch of AstraZeneca Covid-19 vaccines was delivered to Latvia. However, the vaccines appear to have been stored at colder temperature than required, the State Agency of Medicines said in a statement February 8.

The manufacturer's opinion on the use of the vaccines is now awaited, the State Agency of Medicines said. 

When the vaccines were received, it was found that the supplier had allowed for a derogation from the prescribed procedure: the delivery temperature of the vaccines was half a degree cooler than the prescribed +2 C to +8 C temperature.

In order to ensure the full quality of the vaccination process, it is currently requested that the manufacturer AstraZeneca confirm that such derogation has no effect on the quality of the vaccines.

The supplier chosen by the manufacturer shall be responsible for compliance with the transport procedure, including compliance with the temperature regime.

Once approved by the manufacturer, the vaccines will be passed on to the vaccination service providers and the vaccination process will take place as previously planned.

 

Seen a mistake?

Select text and press Ctrl+Enter to send a suggested correction to the editor

Select text and press Report a mistake to send a suggested correction to the editor

Related articles
Crime
Society

Please be aware that the LSM portal uses cookies. By continuing to use this site, you agree that we may store and use cookies on your device. Find out more

Accept and continue